| Q-Pharm offers a wide range of services including:
Phase I and II Clinical Trials and Pharmacokinetic Studies
Q-Pharm’s Phase I clinic trial facilities offers flexible bed
configuration providing a capacity of up to 19 beds with Telemetry and full
patient monitoring available to all areas. We have experience in
the provision of:
- Safety and tolerability clinical studies of new drug candidates
- Pharmacokinetic clinical studies; and
- Drug Interaction Studies
Bioequivalence Studies
The Bioequivalence and pharmacokinetic studies are conducted in a modern, purpose designed 36-bed open-plan ward.
Drug Analysis
Q-Pharm enjoys a strategic alliance with
TetraQ, providing the facility
to undertake the analysis of various clinical samples. TetraQ has
Good Laboratory Practice (GLP) recognition from the National
Association of Testing Authorities (NATA). This GLP status enables
TetraQ’s bioanalytical work (including ELISA assays) to be accepted
internationally for regulatory review and provides clients in the
global biotechnology and pharmaceutical industries with a high degree
of assurance.
Comprehensive Services
Q-Pharm is able to provide a comprehensive service to its clients,
including:
- Study Design
- Protocol Writing
- Conduct of Clinical Studies
- Laboratory Analysis
(via TetraQ)
- Data Analysis, and
- Report Writing
|
